ScienceDirect: Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19

ScienceDirect | Oct. 1, 2021

Print

Tags »

Molnupiravir and Drug Development at Emory